ClinConnect ClinConnect Logo
Search / Trial NCT05960747

Improvement to Perform Thoracocentesis After a Specific Training in Medical Students With the Supervised Use of an Augmented Reality Simulator

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Jul 17, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Thoracentesis Augmented Virtual Reality Simulator Medical Student Training

ClinConnect Summary

This clinical trial is examining how well medical students can learn to perform a procedure called thoracentesis, which is done to remove fluid from the space around the lungs. The study will compare two types of training: one using a special augmented reality simulator, which is like a virtual practice tool, and the other using standard training methods. The goal is to see if the simulator helps students improve their skills better than traditional training.

To participate in this study, medical students must be in their 4th to 6th year of training at the University Hospital of Strasbourg and have never performed a thoracentesis before. They also need to be at least 18 years old and agree to take part in the study. Patients eligible for this study are those who need a thoracentesis for the first time and are over 18, speak French, and have valid health insurance. During the trial, both students and patients will answer surveys about their experiences, including any pain or anxiety felt during the procedure. It’s important to note that this study will not change the care patients receive; it's strictly focused on training students.

Gender

ALL

Eligibility criteria

  • Medical students :
  • Inclusion criteria:
  • Medical students between the 4th and 6th year of their medical course, working in the department of respirology at the University hospital of Strasbourg, France, without any prior experience of thoracocentesis.
  • Older than 18 years old
  • No opposition to participate to the study (signed consent form).
  • Exclusion criteria:
  • - Student with a prior experience of pleural procedure (chest tube, thoracocentesis).
  • Patients :
  • Inclusion criteria:
  • Patients requiring a first-time thoracentesis in routine care.
  • Older than 18 years old.
  • Speaking and understanding French.
  • Valid health insurance.
  • No opposition to participate to the study (signed consent form).
  • Exclusion criteria:
  • Patient with previous experience of pleural procedure (thoracocentesis, chest tube...).
  • Patient having a high-volume pleural effusion according to radiological/ultrasound criteria.
  • Patient with low-volume pleural effusion according to radiological/ultrasound criteria.
  • Patient with poor clinical tolerance of the pleural effusion(respiratory instability, dependence on ventilation machine with positive expiratory pressure...).
  • Patients with higher risk of complication during the procedure (BMI \> 35 kg/m², with increased risk of bleeding...).
  • Contraindication to the use of Lidocaine.
  • Local infection.
  • Impossibility to provide detailed information to the patient.
  • Subject under legal protection.

About University Hospital, Strasbourg, France

The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.

Locations

Strasbourg, , France

Strasbourg, Bas Rhin, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported